By Professor Arun Vishwanathan Krishnan

Journal articles

Arnold R; Huynh W; Kiernan MC; Krishnan AV, 2015, 'Ion channel modulation as a therapeutic approach in multiple sclerosis', Current Medicinal Chemistry, 22, pp. 4366 - 4378, http://dx.doi.org/10.2174/0929867322666151029104452

Krishnan AV, 2015, 'Polyneuropathy in POEMS syndrome: Alterations in nerve function and morphology', Clinical Neurophysiology, 126, pp. 1845 - 1846, http://dx.doi.org/10.1016/j.clinph.2015.01.015

Krishnan AV, 2015, 'Ion channel dysfunction and peripheral nerve hyperexcitability', Clinical Neurophysiology, 126, pp. 1069 - 1070, http://dx.doi.org/10.1016/j.clinph.2014.09.012

Kwai N; Arnold R; Poynten AM; Lin CSY; Kiernan MC; Krishnan AV, 2015, 'Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus', Diabetes/Metabolism Research and Reviews, 31, pp. 175 - 182, http://dx.doi.org/10.1002/dmrr.2583

Krishnan AV, 2015, 'Polyneuropathy in POEMS syndrome: Alterations in nerve function and morphology', Clinical Neurophysiology, http://dx.doi.org/10.1016/j.clinph.2015.01.015

Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CSY; Krishnan AV; Lewis CR; Kiernan MC; Goldstein D, 2014, 'Paclitaxel-induced neuropathy: Potential association of MAPT and GSK3B genotypes', BMC Cancer, 14, pp. 993, http://dx.doi.org/10.1186/1471-2407-14-993

Huynh W; Lin CSY; Krishnan AV; Vucic S; Kiernan MC, 2014, 'Transynaptic Changes Evident in Peripheral Axonal Function After Acute Cerebellar Infarct', Cerebellum, 13, pp. 669 - 676, http://dx.doi.org/10.1007/s12311-014-0577-0

Cohen JA; Krishnan AV; Goodman AD; Potts J; Wang P; Havrdova E; Polman C; Rudick RA, 2014, 'The clinical meaning of walking speed as measured by the Timed 25-Foot Walk in patients with multiple sclerosis', JAMA Neurology, 71, pp. 1386 - 1393, http://dx.doi.org/10.1001/jamaneurol.2014.1895

Park SB; Lin CSY; Krishnan AV; Simon NG; Bostock H; Vincent A; Kiernan MC, 2014, 'Axonal dysfunction with voltage gated potassium channel complex antibodies', Experimental Neurology, 261, pp. 337 - 342, http://dx.doi.org/10.1016/j.expneurol.2014.06.002

Farrar MA; Park SB; Krishnan AV; Kiernan MC; Lin CSY, 2014, 'Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies', Muscle and Nerve, 49, pp. 858 - 865, http://dx.doi.org/10.1002/mus.24085

Krishnan AV; Park SB, 2014, 'Chemotherapy-induced peripheral neuropathy: The end of the beginning?', Journal of Neurology, Neurosurgery and Psychiatry, 85, pp. 359, http://dx.doi.org/10.1136/jnnp-2013-305600

Arnold R; Pussell BA; Howells J; Grinius V; Kiernan MC; Lin CSY; Krishnan AV, 2014, 'Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease', Clinical Neurophysiology, 125, pp. 179 - 185, http://dx.doi.org/10.1016/j.clinph.2013.06.022

Carcel C; Matar W; Krishnan A, 2014, '12. Co-existence of primary progressive MS and CMT1A', Clinical Neurophysiology, 125, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2013.10.034

Eviston TJ; Lin CS-Y; Krishnan AV, 2014, '13. A protocol for the assessment of Facial Nerve excitability properties', Clinical Neurophysiology, 125, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2013.10.035

Murray JE; Pickering HR; Lin CS-Y; Goldstein D; Friedlander ML; Kiernan MC; Krishnan AV, 2014, '6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.028

Pickering H; Lin CS-Y; Murray J; Kiernan MC; Krishnan AV, 2014, '7. Effects of fampridine PR on axonal function in multiple sclerosis', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.029

Huynh W; Vucic S; Krishnan AV; Lin CS-Y; Kiernan MC, 2014, '8. Evolution and recovery of motor function post-stroke', Clinical Neurophysiology, 125, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2013.10.030

Huynh W; Krishnan AV; Vucic S; Lin CSY; Kiernan MC, 2013, 'Motor cortex excitability in acute cerebellar infarct', Cerebellum, 12, pp. 826 - 834, http://dx.doi.org/10.1007/s12311-013-0493-8

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204

Arnold R; Kwai NCG; Krishnan AV, 2013, 'Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies', Clinical Neurophysiology, 124, pp. 2079 - 2090, http://dx.doi.org/10.1016/j.clinph.2013.04.012

Arnold R; Pussell BA; Pianta TJ; Lin CSY; Kiernan MC; Krishnan AV, 2013, 'Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients', American Journal of Transplantation, 13, pp. 2426 - 2432, http://dx.doi.org/10.1111/ajt.12324

Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204

Arnold R; Kwai NCG; Lin CS-Y; Poynten AM; Kiernan MC; Krishnan AV, 2013, 'Axonal dysfunction prior to neuropathy onset in type 1 diabetes', Diabetes - Metabolism Research and Reviews, 29, pp. 53 - 59, http://dx.doi.org/10.1002/dmrr.2360

Arnold R; Pussell B; Pianta T; Grinius V; Lin CS-Y; Kiernan MC; Howells J; Jardine MJ; Krishnan AV, 2013, 'Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease', PLoS ONE, 8, pp. Article number e59055, http://dx.doi.org/10.1371/journal.pone.0059055

Kwai N; Arnold R; Wickrema C; Poynten A; Kiernan M; Krishnan A, 2012, '20. Effects of altered axonal biophysical properties on quality of life in diabetic peripheral neuropathy', Clinical Neurophysiology, 123, pp. e75 - e75, http://dx.doi.org/10.1016/j.clinph.2011.11.029

Huynh W; Krishnan AV; Vucic S; Lin CS-Y; Hornberger M; Kiernan MC, 2012, '4. Unmasking the mechanisms of neuroplasticity in stroke: A study of the entire neural axis', Clinical Neurophysiology, 123, pp. e70 - e70, http://dx.doi.org/10.1016/j.clinph.2011.11.013

Sung J; Park SB; Liu Y; Kwai N; Arnold R; Krishnan AV; Lin CS-Y, 2012, 'Progressive axonal dysfunction precedes development of neuropathy in type 2 Diabetes.', Diabetes, 61, pp. 1592 - 1598, http://dx.doi.org/10.2337/db11-1509

Lin CS-Y; Krishnan AV; Park SB; Kiernan MC, 2011, 'Modulatory Effects on Axonal Function After Intravenous Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy', Archives of Neurology, 68, pp. 862 - 869

Cheah BC; Vucic S; Krishnan AV; Boland R; Kiernan MC, 2011, 'Neurophysiological index as a biomarker for ALS progression: Validity of mixed effects models', Amyotrophic Lateral Sclerosis, 12, pp. 33 - 38, http://dx.doi.org/10.3109/17482968.2010.531742

Krishnan AV; Park SB; Payne ; Lin C; Vucic S; Kiernan MC, 2011, 'Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy', Clinical Neurophysiology, 122, pp. 194 - 198, http://dx.doi.org/10.1016/j.clinph.2010.04.038

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002

Arnold R; Pianta T; Pussell B; Grinius V; Lin C; Kiernan M; Jardine M; Krishnan A, 2010, 'DIFFERENTIAL EFFECTS OF HAEMODIAFILTRATION ON HIGH FLUX HAEMODIALYSIS ON NERVE FUNCTION IN VITRO', NEPHROLOGY, 15, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2010, '5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.025

Farrar MA; Lin CS-Y; Krishnan A; Park SB; Andrews PI; Kiernan MC, 2010, '6. Axonal energy failure during a stroke-like episode in MELAS', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.026

Farrar M; Lin CS-Y; Krishnan AV; Park SB; Andrews PI; Kiernan MC, 2010, 'Acute, reversible axonal energy failure during stroke-like episodes in MELAS', Pediatrics, 126, pp. e734 - e739

Marsh EA; Hirst CL; Llewelyn JG; Cossburn MD; Reilly MM; Krishnan A; Doran M; Ryan AM; Coles AJ; Jones JL; Robertson NP, 2010, 'Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.', J Neurol, 257, pp. 913 - 919, http://dx.doi.org/10.1007/s00415-009-5437-3

Cheah B; Vucic O; Krishnan AV; Kiernan MC, 2010, 'Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 17, pp. 1942 - 1959, http://www.benthamdirect.org/pages/content.php?CMC/2010/00000017/00000018/0006C.SGM

Krishnan AV; Lin CS; Kiernan MC, 2009, '125. Conduction failure and fatigue in diabetic neuropathy', Journal of Clinical Neuroscience, 16, pp. 468 - 469, http://dx.doi.org/10.1016/j.jocn.2008.07.025

Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, 27, pp. 1243 - 1249

Krishnan AV; Fulham MJ; Kiernan MC, 2009, 'Another Cause of Occupational Entrapment Neuropathy: La Main Du Cuisinier (The Chef's Hand)', Journal of Clinical Neurophysiology, 26, pp. 129 - 131, http://journals.lww.com/clinicalneurophys/pages/articleviewer.aspx?year=2009&issue=04000&article=00011&type=abstract

Krishnan AV; Lin CS-Y; Park SB; Kiernan MC, 2009, 'Axonal ion channels from bench to bedside: A translational neuroscience', Progress in Neurobiology, 89, pp. 288 - 313

Krishnan AV; Lin CS; Reddel SW; Mcgrath R; Kiernan MC, 2009, 'Conduction block and impaired axonal function in tick paralysis', Muscle and Nerve, 40, pp. 358 - 362

Krishnan AV; Lin CS-Y; Park SB; Kiernan MC, 2009, 'Diabetic Neuropathy and the Development of a Novel Biomarker', Journal of Clinical Neuroscience, 16, pp. 1519 - 1519, http://dx.doi.org/10.1016/j.jocn.2009.07.018

Lin CS-Y; Krishnan AV; Park S; Kiernan MC, 2009, 'Effects of Immunotherapy on Nerve Excitability in Patients with Chronic Inflammatory Demyelinating Polyneuropathy', Journal of Clinical Neuroscience, 16, pp. 1519 - 1520, http://dx.doi.org/10.1016/j.jocn.2009.07.019

Han SH; Boland R; Krishnan AV; Vucic S; Lin CS-Y; Kiernan MC, 2009, 'Ischaemic sensitivity of axons in carpal tunnel syndrome', Journal of the Peripheral Nervous System, 14, pp. 190 - 200

Krishnan AV; Kiernan MC, 2009, 'Neurological complications of chronic kidney disease', Nature Reviews Neurology, 5, pp. 542 - 551

Krishnan AV; Pussell BA; Kiernan MC, 2009, 'Neuromuscular Disease in the Dialysis Patient: An Update for the Nephrologist', Seminars in Dialysis, 22, pp. 267 - 278, http://www3.interscience.wiley.com/journal/122304819/abstract

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced Lhermitte’s phenomenon as a manifestation of severe generalized nerve dysfunction', Oncology, 77, pp. 342 - 348

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, 132, pp. 2712 - 2723

Vucic O; Cheah B; Krishnan AV; Burke DJ; Kiernan MC, 2009, 'The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition', Brain Research, 1, pp. 39 - 47, http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6SYR-4VY2CBH-H&_user=37161&_coverDate=06%2F01%2F2009&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000004218&_version=1&_urlVersion=0&_userid=37161&md5=e9e0beca267bc33552673749e70b1c4d

Back to profile page